RSS

Reece Armstrong

Reece Armstrong RLS

Reece Armstrong is a reporter for Digital Health Age, Medical Plastics News, European Pharmaceutical Magazine and Med-Tech Innovation. He has a MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. His interests include health, technology, videogames and he is a keen performer of live original music.

He can be contacted at reece.armstrong@rapidnews.com

Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma. Read more

Opinion

Reece Armstrong examines Scott Gottlieb's legacy on the FDA and what it means for pharmaceutical manufacturers. Read more

Latest Issue

Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world. Read more

Opinion

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

EPM editor Reece Armstrong examines the impact a no-deal Brexit would place on medicines supply in the UK. Read more

Opinion

With the potential of antimicrobial resistance (AMR) taking our modern medicine practices back to the stone age, governments around the world need to face the threat head on. Read more

Opinion

In his first Editor's Desk focus, Reece Armstrong asks whether it's time pharmaceutical manufacturers change their approaches to the way drugs are developed, in response to changing healthcare needs around the world. Read more

Latest Issue

Medical device maker, Phillips-Medisize has released a connected health platform to help improve the way people take medication when using connected health devices. Read more

Technology

Digital Innovations Hubs are to be created in the UK to help connect data and fast-track treatments for a range of important diseases like cancer, heart disease and asthma. Read more

News

In the last of a series of articles surrounding the Pfizer Healthcare Hub: London, founder and CEO of Illumr, Jason Lee, talks to reporter Reece Armstrong about the use of AI and data within healthcare. Read more

News

In the second of a series of articles surrounding the Pfizer Healthcare Hub: London, Medopad’s Alex Gilbert, Partnerships, sits down with Digital Health Age reporter Reece Armstrong to discuss how remote patient monitoring is impacting patient care. Read more

News

Manager for the Pfizer Healthcare Hub: London, Dr Hamish Graham, talks to reporter Reece Armstrong about how the Hub is helping healthtech start-ups across the UK and why digital innovation is vital to the NHS. Read more

News

A delegation from Manchester is heading to the US to showcase the city’s strength in the life sciences sector. Read more

News

Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services. Read more

Technology

Three healthtech start-ups have been selected by biopharmaceutical company Pfizer to help get their technologies adopted onto the NHS. Read more

News

Global pharmaceutical company Roche has acquired a mobile diabetes platform to bolster its digital health services. Read more

News

A dissolvable adhesive patch has been developed to offer a ‘painless’ alternative to the flu vaccine, which is traditionally delivered by injection. Read more

Technology

The FDA has released a statement regarding plans that help regulate digital health technologies. Read more

News

Life sciences organisations MedCity and the Northern Health Science Alliance (NHSA) have called upon the newly formed government to reinstate a life sciences minister. Read more

News

The potential benefits of genomics are well documented in healthcare, European Pharmaceutical Manufacturer reporter Reece Armstrong examines the latest developments in the field. Read more

Opinion